Principal Investigator
Martin Gleave

Overview

Body Locations and Systems
Prostate Cancer
Disorders and Conditions
Cancers
ClinicalTrials.gov#
NCT02257736
Status
Closed for Recruitment
Start/End Dates
Name/Title
Maureen Palmer, Research Coordinator
Phone
604-875-5675
Email Address
maureen.palmer@vch.ca
Purpose of Study

The purpose of this study is to compare the radiographic progression-free survival (rPFS) of JNJ56021927 in combination with abiraterone acetate (AA) plus prednisone or prednisolone (AAP) and AAP in participants with chemotherapy-naive (participants who did not receive any chemotherapy [treatment of cancer using drugs]) metastatic castration-resistant prostate cancer (mCRPC) (cancer of prostate gland [gland that makes fluid that aids movement of sperm]).

Eligibility

Visit ClinicalTrials.gov for more information. 

Disclaimer

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.